Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

24 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 12.5MG TABLET Resolved 2020-11-06 2021-02-05 128016
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 12.5MG TABLET Resolved 2020-11-06 2020-12-18 128049
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 25MG TABLET Resolved 2020-12-17 2020-12-18 130313
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 12.5MG TABLET Resolved 2021-01-07 2021-03-25 131087
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 25MG TABLET Resolved 2021-01-07 2021-01-14 131090
TEVA-LISINOPRIL/HCTZ (TYPE Z) 10MG 12.5MG TABLET Resolved 2021-01-15 2021-02-05 131700
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-02-02 2023-02-16 183398
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2023-06-08 2023-07-06 194119
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-06-08 2023-06-27 194122
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2023-06-16 2023-08-04 195033
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-06-16 2023-06-27 195124
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-06-16 2023-06-27 195204
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2023-06-19 2023-07-14 195597
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-07-04 2023-08-04 197104
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 10MG TABLET Resolved 2023-07-18 2023-10-03 199103
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-08-17 2023-10-04 202278
TEVA-LOPERAMIDE 2MG TABLET Resolved 2018-03-13 2018-05-30 42591
TEVA-LOPERAMIDE 2MG TABLET Resolved 2018-03-13 2018-05-30 42594
TEVA-LOPERAMIDE 2MG TABLET Resolved 2020-06-25 2020-07-23 118925
TEVA-LOPERAMIDE 2MG TABLET Resolved 2022-07-25 2022-10-01 165441

Showing 1581 to 1600 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393

Showing 61 to 80 of 250